medline.ch Onkologie Gynäkologische Tumoren

	Cost-effectiveness of Integrated FDG PET/MR with Low-dose Chest CT for Initial Staging of Locally Advanced Breast Cancer. J Am Coll Radiol Asmundo L, Blandino AA, Quiros E, Harrington SG, Czawlytko C, Gowda V, Umutlu L, Catalano OA. PMID: 42191008 [PubMed - as supplied by publisher]
	HER2-targeted PET/CT in breast cancer: a systematic review of lesion-level concordance with pathology. Eur J Radiol Burén SA, Romdhani NS, Ulaner G, Yeh R, Tran TA, Axelsson R, Altena R. PMID: 42190547 [PubMed - as supplied by publisher]
	The CHRONO trial: Protocol for a randomized controlled trial of early time-restricted eating in patients with breast or rectal cancer. Nutr Res Salvy SJ, Figueiredo JC, Atkins KM, Hollis RH, Jahan N, Gunnells DJ, Sleight AG, Gresham G, Diniz MA, Richman JS, Gong J, Zaghiyan K, Heslin MJ, Lee KJ, Sarfraz H, Peterson CM. PMID: 42190452 [PubMed - as supplied by publisher]
	Association between chemotherapy use and prognosis in young patients with stage I-II ER+â€¯/HER2-negative breast cancer according to ProsignaÂ®: An international real-world analysis with propensity-score matching. Eur J Cancer Di Grazia G, Di Lauro V, Morchón-Araujo D, Nucera S, Figuero-Pérez L, Calleja-Holgado FJ, Pelegrina Sánchez D, Wallbaum B, Rivera Vargas P, Palleschi M, Musolino A, Zatta Cobos G, López Paradís A, Barroso G, Cano Cano O, Dalmau Portulas E, Caltavituro A, Buono G, Jerez Gillaranz Y, Echavarría I, López-Tarruella S, Bergamino Sirvén M, Martínez-Sáez O, Adamo B, Muñoz Mateu M, Arpino G, Sánchez Bayona R, De Laurentiis M, Rodríguez CA, Pascual T, Vidal Losada M, Schettini F. PMID: 42190396 [PubMed - as supplied by publisher]
	Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis. Cancer Epidemiol Yabrude ATZ, Reis LCS, Anchía AJR, Dos Santos TAE, de Albuquerque CFA, Del Fiol Manna E. PMID: 42190326 [PubMed - as supplied by publisher]
	Planning and Developing a Symptom Diary Intervention for Breast Cancer Survivors With Concerns About Medication Brands (ENABLE Study): User-Centered Design Approach. JMIR Cancer Eraso Y, Stewart D, Edwards R, Nanray B, Cochrane J. PMID: 42190242 [PubMed - indexed for MEDLINE]
	Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial. Clin Cancer Res Martín M, Rodriguez-Lescure A, Reboredo C, Chen E, Ruiz-Borrego M, Santaballa Bertran A, Rodríguez CA, Martinez Jañez N, Alba E, Tran K, Pelaez Fernandez I, Álvarez I, Seguí MA, De la Cruz A, Valero V, Antón-Torres A, Andrés R, Amillano K, Ponce-Lorenzo JJ, Dominguez Fernandez S, Herranz J, Rincon R, Caballero R, Guerrero-Zotano A, Rojo F, Symmans WF. PMID: 42189890 [PubMed - as supplied by publisher]
	Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer. Clin Cancer Res Schmid P, Ma CX, Park YH, Lord S, Armstrong A, Im SA, Chen SC, Fernandes R, Jassem J, Wysocki PJ, Lu YS, Wang HC, Chung WP, Rao-Melacini P, Heider K, Stewart R, Vukovi, Jung KH. PMID: 42189888 [PubMed - as supplied by publisher]
	PiggyBac-engineered membrane-bound IL-7 TILs combined with anti-PD-1 antibody demonstrates efficacy in recurrent ovarian cancer: a first-in-human phase 1 trial. Clin Cancer Res Guo J, Wu Y, Huang W, Ai G, Wang C, Luo N, Zhu J, Zhou Y, Shi W, Ding J, Ge Y, Feng W, Jin H, Zhao B, Cheng Z. PMID: 42189877 [PubMed - as supplied by publisher]
	Accurate Phenotyping at the Single-Exosome Level Using a Proximity-Ligation RCA-Based Light-Scattering Counting Platform for Breast Cancer Diagnosis. ACS Sens Zhang B, Zhang P, Li M, Liang Y, Liu Z, Wang F, Li Z. PMID: 42189780 [PubMed - as supplied by publisher]
	The Impact of Pilates Exercise on the Overall Health of Patients With Breast Cancer: A Systematic Review and Meta-Analysis. Oncol Nurs Forum Ryu S, Im A, Kim S. PMID: 42189649 [PubMed - indexed for MEDLINE]
	The additive value of 3D automated breast ultrasound and contrast enhanced spectral mammography in the assessment of suspicious breast lesions. J Egypt Natl Canc Inst ELmalatawy LH, Elsaid NAE. PMID: 42189453 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis After Neoadjuvant Therapy for Patients with Clinically Node-Negative Hormone Receptor-Positive, HER2-Negative Breast Cancer. Ann Surg Oncol Wanis KN, Krasniqi R, Sun SX, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. PMID: 42189440 [PubMed - as supplied by publisher]
	Comprehensive insight into nimbolide response against breast cancer treatment: present evidence, emerging strategy and future direction. Mol Biol Rep Sarangi A, Kashyap A, Panda SS, Sahoo S, Sahoo SK. PMID: 42189294 [PubMed - indexed for MEDLINE]
	Adverse childhood experiences, adult adiposity, and risk of young-onset breast cancer subtypes in a population-based case-control study. Cancer Causes Control Marcus Post L, Cho YI, Topitzes J, Do D, Pathak DR, Hamilton AS, Nuru-Jeter AM, Hirko KA, Kwarteng JL, Houang R, Schwartz AG, Velie EM. PMID: 42189276 [PubMed - indexed for MEDLINE]
	Primary care continuity and breast cancer survival: a retrospective cohort study. Cancer Causes Control Walsh R, Lofters A, Groome P, Moineddin R, Krzyzanowska MK, Griffiths R, Grunfeld E. PMID: 42189262 [PubMed - indexed for MEDLINE]
	Geospatial heterogeneity of hotspots for incidence and late-stage diagnosis of breast, colorectal, and lung cancer. Cancer Causes Control Loehrer AP, Carlos HA, Weiss JE, Wang Q, Leversedge CV, Katter JE, Phillips JD, Ferrari-Light D, Onega T, Shi X. PMID: 42189260 [PubMed - indexed for MEDLINE]
	Thyroid disease and breast cancer risk in the Sister Study. Cancer Epidemiol Biomarkers Prev Woo JMP, Chen D, Yarosh R, O'Brien KM, Sandler DP. PMID: 42189187 [PubMed - as supplied by publisher]
	Revolutionizing breast cancer treatment: the emerging role of biopolymers-based drug-eluting nanofibers. J Biomater Sci Polym Ed H Ali I, Hamdi M, Abouzid K, Abdel-Bar HM. PMID: 42189080 [PubMed - as supplied by publisher]
	Bidirectional Perceptual Multimodal Interaction Network Based on Contrastive Learning for Breast Cancer pCR Prediction. Tomography Feng J, Jiang Z, Zhang J. PMID: 42188715 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 329246

Seite 1 von 16463

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung